Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Carillion inks definitive sale agreement for disposal of bulk of its UK healthcare facilities business

The firm said an agreed proportion of the total consideration of approximately £47.7mln will be payable in instalments on the transfer of each facilities management arrangement
Carillion staff
Carillion issued its third profit warning in five months in November and said it was heading towards a breach of debt covenants

Carillion PLC (LON:CLLN) has now entered into a definitive sale agreement with Serco PLC (LON:SRP) for the disposal of a large part of its UK healthcare facilities management business.

Further to its announcement on October 24, the struggling construction contractor said today that a portfolio of UK healthcare facilities management contracts and associated ancillary contracts and assets which relate to fifteen sites will be transferred to Serco on a phased basis.

READ: Carillion shares up as stock overhang cleared after biggest shareholder, Kiltearn halves stake

The firm said an agreed proportion of the total consideration of approximately £47.7mln will be payable in instalments on the transfer of each facilities management arrangement to Serco, with the aim of receiving the bulk of the proceeds in the second and third quarters of 2018

After taking account of fees, costs and taxes, it added, the net disposal proceeds are expected to be £41.4mln which will used to reduce the firm’s debt.

Keith Cochrane, Carillion's Interim chief executive, said: “I am pleased we have been able to successfully conclude this transaction which will contribute to our efforts to reduce net debt."

Carillion issued its third profit warning in five months in November and said it was heading towards a breach of debt covenants and would need fresh capital.

READ: Carillion fighting for survival after third profit warning

The group's shares have slumped by over 90% since it first issued a profit warning and its CEO quit in July but have been rallying this week helped by the clearance of a stock overhang after Scottish investment firm Kiltearn Partners, the firm’s largest shareholder was revealed to have halved its stake in the company.

Kiltearn cut its stake in Carillion to 4.94% on December 7, down from 9.85% previously, a notification of major holdings statement revealed.

In late morning trading, Carillion shares held steady at 17.5p.

 -- Adds share price --

View full CLLN profile View Profile

Carillion Timeline

Related Articles

John Arnold
September 25 2017
“We are trying to find value all of the time," John Arnold, chief executive

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use